This article is about a non-clinically used compound. For the pharmaceutical drug, see Estramustine phosphate.
 | |
 | |
| Clinical data | |
|---|---|
| Trade names | Emcyt, Estracyt |
| Other names | EM; EaM; Leo 275; Ro 21-8837; Estradiol 3-(bis(2-chloroethyl)carbamate) ester; Estra-1,3,5(10)-triene-3,17β-diol 3-(bis(2-chloroethyl)carbamate) ester |
| Drug class | Chemotherapeutic agent; Estrogen; Estrogen ester |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.019.161 |
| Chemical and physical data | |
| Formula | C23H31Cl2NO3 |
| Molar mass | 440.41 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Estramustine (INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name, BANTooltip British Approved Name) is an estrogen and cytostatic antineoplastic agent which was never marketed.[1][2] It is an estrogen ester – specifically, the C3 normustine ester of estradiol – and acts in part as a prodrug of estradiol in the body.[1][2] Estramustine phosphate, the C17β phosphate ester of estramustine and a prodrug of estramustine, estromustine, estradiol, and estrone, is marketed and used in the treatment of prostate cancer.[1][2]
See also
References
- 1 2 3 Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 502–. ISBN 978-1-4757-2085-3.
- 1 2 3 Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 406–. ISBN 978-3-88763-075-1.
| ERTooltip Estrogen receptor |
| ||||||
|---|---|---|---|---|---|---|---|
| GPERTooltip G protein-coupled estrogen receptor |
| ||||||
| |||||||
| ARTooltip Androgen receptor |
| ||||||
|---|---|---|---|---|---|---|---|
| GPRC6A |
| ||||||
| |||||||
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.